ORBIMED ADVISORS LLC Dyne Therapeutics, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$2.79M
portfolio value

Dyne Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 220.4K shares 2.79M $12.7 220.4K
Q3 2021 share Decrease -100.00% -350K shares -7.36M $16.24 0
Q2 2021 share 0.00% 0 shares 1.92M $21.04 350K
Q1 2021 share 0.00% 0 shares -1.91M $15.53 350K
Q4 2020 share 0.00% 0 shares 283K $21 350K
Q3 2020 share Increase 0.00% 350K shares 7.06M $20.19 350K